We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACNT icon
4626
Ascent Industries
ACNT
$133M
$9K ﹤0.01%
611
+20
+3% +$297
ACXP icon
4627
Acurx Pharmaceuticals
ACXP
$6.36M
$9K ﹤0.01%
145
+57
+65% +$4.27K
AIMD icon
4628
Ainos
AIMD
$11M
$9K ﹤0.01%
+192
New +$10.1K
ALGS icon
4629
Aligos Therapeutics
ALGS
$43.7M
$9K ﹤0.01%
322
-424
-57% -$14.1K
ALTI icon
4630
AlTi Global
ALTI
$457M
$9K ﹤0.01%
948
-528
-36% -$5.22K
ALTL icon
4631
Pacer Lunt Large Cap Alternator ETF
ALTL
$92.1M
$9K ﹤0.01%
261
-3,626
-93% -$149K
APVO icon
4632
Aptevo Therapeutics
APVO
$5.31M
0
ASUR icon
4633
Asure Software
ASUR
$241M
$9K ﹤0.01%
1,564
+1,472
+1,600% +$8.04K
BFRI icon
4634
Biofrontera
BFRI
$16.1M
$9K ﹤0.01%
+433
New +$11.8K
BJDX icon
4635
Bluejay Diagnostics
BJDX
$1.1M
0
BLZE icon
4636
Backblaze
BLZE
$1.26B
$9K ﹤0.01%
1,819
+1,789
+5,963% +$10.7K
BOXL icon
4637
Boxlight
BOXL
$4.54M
$9K ﹤0.01%
10
-4
-29% -$3.72K
BWEN icon
4638
Broadwind
BWEN
$129M
$9K ﹤0.01%
2,908
+2,411
+485% +$6.14K
BYFC icon
4639
Broadway Financial
BYFC
$105M
$9K ﹤0.01%
1,037
-3,353
-76% -$28.6K
CNA icon
4640
CNA Financial
CNA
$13.7B
$9K ﹤0.01%
257
-4
-2% -$163
PRHI
4641
Presurance Holdings
PRHI
$15.4M
$9K ﹤0.01%
840
+49
+6% +$602
COOK icon
4642
Traeger
COOK
$172M
$9K ﹤0.01%
62
-73
-54% -$12.3K
CPIX icon
4643
Cumberland Pharmaceuticals
CPIX
$119M
$9K ﹤0.01%
3,531
-1,367
-28% -$3.22K
CWEB icon
4644
Direxion Daily CSI China Internet Index Bull 2X ETF
CWEB
$226M
$9K ﹤0.01%
+226
New +$12.3K
DRRX
4645
DELISTED
DURECT Corp
DRRX
$9K ﹤0.01%
1,520
-1,116
-42% -$6.8K
EEMA icon
4646
iShares MSCI Emerging Markets Asia ETF
EEMA
$871M
$9K ﹤0.01%
+161
New +$10.5K
EEX
4647
DELISTED
Emerald Holding
EEX
$9K ﹤0.01%
2,744
-16,863
-86% -$60.9K
EP icon
4648
Empire Petroleum
EP
$108M
$9K ﹤0.01%
703
-16
-2% -$200
EWZ icon
4649
iShares MSCI Brazil ETF
EWZ
$8.55B
$9K ﹤0.01%
303
-3,787
-93% -$112K
FEMY icon
4650
Femasys
FEMY
$7.1M
$9K ﹤0.01%
419
-84
-17% -$3.16K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.